Tocilizumab in severe COVID-19

被引：3
|
作者：
Liberato, Nicola Lucia [1 ]
De Monte, Andrea [2 ]
Caravella, Giuseppe [3 ]
机构：
[1] ASST Melegnano & Martesana, Dept Med, Vizzolo Predabissi, MI, Italy
[2] ASST Melegnano & Martesana, Dept Oncol, Vizzolo Predabissi, MI, Italy
[3] ASST Melegnano & Martesana, Dept Pharm, Vizzolo Predabissi, MI, Italy
来源：
ARCHIVES OF MEDICAL SCIENCE | 2020年 / 16卷 / 06期
关键词：
D O I：
10.5114/aoms.2020.97411
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1457 / 1458
页数：2
相关论文
共 50 条
  • [41] THERAPEUTIC OUTCOMES FOLLOWING TOCILIZUMAB ADMINISTRATION IN PATIENTS WITH SEVERE COVID-19
    Kline, Jonathan
    Patel, Payal
    Palma, Stephanie
    Pasqualicchio, Michael
    Clarke, Heidi
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 84 - 84
  • [42] Clinical experience with tocilizumab in the treatment of pregnant woman with severe COVID-19
    Riabokon, O., V
    Kuliesh, I. O.
    Furyk, O. O.
    Matvieieva, T. B.
    Kalashnyk, K., V
    [J]. PATHOLOGIA, 2022, 19 (01): : 79 - 83
  • [43] Tocilizumab for severe COVID-19: a systematic review and meta-analysis
    Lan, Shao-Huan
    Lai, Chih-Cheng
    Huang, Hui-Ting
    Chang, Shen-Peng
    Lu, Li-Chin
    Hsueh, Po-Ren
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (03)
  • [44] Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab
    Salvati, Lorenzo
    Occhipinti, Mariaelena
    Gori, Leonardo
    Ciani, Luca
    Mazzoni, Alessio
    Maggi, Laura
    Capone, Manuela
    Parronchi, Paola
    Liotta, Francesco
    Miele, Vittorio
    Annunziato, Francesco
    Lavorini, Federico
    Cosmi, Lorenzo
    [J]. IMMUNOLOGY LETTERS, 2020, 228 : 122 - 128
  • [45] Comment: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    [J]. ANNALS OF PHARMACOTHERAPY, 2023, 57 (09) : 1117 - 1117
  • [46] Clinical practice guideline: tocilizumab for patients with severe and critical COVID-19
    Ragusa, Martin A.
    Tortosa, Fernando
    Carrasco, Gabriela
    Montero, Guadalupe
    Haluska, Pedro
    Lamfre, Laura
    Izcovich, Ariel
    [J]. MEDICINA-BUENOS AIRES, 2021, 81 (06) : 1015 - 1035
  • [47] Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients
    Guz, Dmitri
    Gafter-Gvili, Anat
    Lev, Nirit
    Levin, Gal Sahaf
    Lev, Shaul
    [J]. ACTA HAEMATOLOGICA, 2022, 145 (04) : 440 - 446
  • [48] Reply: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19
    Lewis-Wolfson, Temeka Dawn
    Joyner, Kayla Rena
    [J]. ANNALS OF PHARMACOTHERAPY, 2023, 57 (09) : 1118 - 1119
  • [49] Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients
    Zeng, Jia
    Xie, Ming-Hui
    Yang, Jing
    Chao, Sheng-Wu
    Xu, Er-Li
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (17) : 3763 - 3773
  • [50] Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study
    Kewan, Tariq
    Covut, Fahrettin
    Al-Jaghbeer, Mohammed J.
    Rose, Lori
    Gopalakrishna, K., V
    Akbik, Bassel
    [J]. ECLINICALMEDICINE, 2020, 24
12345